Frontpage » Tag » ranibizumab

News tagged with ranibizumab


Ranibizumab no better than saline for vitreous hemorrhage

(HealthDay)—For patients with vitreous hemorrhage from proliferative diabetic retinopathy (PDR), the probability of vitrectomy within 16 weeks after intravitreal injections of ranibizumab or saline is lower ...

Ophthalmology created Feb 01, 2013 | popularity not rated yet | comments 0

Study suggests caution and further studies on drugs used to treat macular degeneration

Millions of people with "wet" macular degeneration are prescribed a class of medication known as anti-VEGF drugs. But now scientists at The Scripps Research Institute (TSRI) have found that a drastic reduction of VEGF activity ...

Cancer created Oct 25, 2012 | popularity not rated yet | comments 0 | with audio podcast

Long-term ranibizumab beneficial for macular edema

(HealthDay)—Long-term aggressive treatment of patients with macular edema with ranibizumab during a third year correlates with reduced mean foveal thickness (FTH) and improved best-corrected visual acuity ...

Ophthalmology created Oct 11, 2012 | popularity not rated yet | comments 0

Avastin and Lucentis are equivalent in treating age-related macular degeneration

At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although ...

Ophthalmology created Apr 30, 2012 | popularity not rated yet | comments 1

Researchers find better way to save sight

People who are losing their eyesight through aged-related macular degeneration (AMD) may soon be able to find out if a commonly used drug can help save their vision.

Ophthalmology created Mar 15, 2012 | popularity 5 / 5 (2) | comments 0

Mayo Clinic detective work shows possible side effect in macular degeneration drug

Two major drug trials conclude there was little risk from a drug aimed at age-related macular degeneration. Yet a Mayo Clinic ophthalmologist began to note something concerning in some of her patients: an increase in pressure ...

Diseases, Conditions, Syndromes created Oct 24, 2011 | popularity not rated yet | comments 0

Study estimates potential for ranibizumab to prevent blindness from age-related macular degeneration

A computer modeling study suggests that administering the drug ranibizumab is associated with reducing the magnitude of legal blindness and visual impairment caused by age-related macular degeneration in non-Hispanic white ...

Ophthalmology created Jun 13, 2011 | popularity not rated yet | comments 0